In vitro evidence that GATA2 plays a role in prostate cancer metastasis, and the finding that its elevated expression in clinical metastatic prostate cancer tissues correlates with poor patient prognosis, suggest that the GATA2 gene is a potential prostate cancer metastasis-driving gene. The gene discussed is GATA2; the disease is Familial prostate cancer.